CADL · Candel Therapeutics, Inc.

$12.78 -0.29 (-2.20%)

Russell 2000 member Rebalance outlook locked

Market Cap

$1.00B

76.52M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Paul Peter Tak	M.D., Ph.D., FMedSci, Chief Executive Officer	$743,592	—	—	$3,916,028	$396,653	$288,289	$5,344,561
Francesca Barone	M.D., Chief Scientific Officer	$483,312	—	—	$857,797	$206,427	$14,000	$1,561,536
Charles Schoch	Chief Financial Officer	$398,500	—	—	$826,465	$232,320	$13,532	$1,470,817

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Paul Peter Tak	M.D., Ph.D, FMedSci, Chief Executive Officer	$688,940	—	—	—	$498,061	$262,221	$1,449,222
Francesca Barone	M.D., Chief Scientific Officer	$443,303	—	—	—	$269,119	$13,800	$726,222
Seshu Tyagarajan	Ph.D., RAC Chief Technical and Development Officer	$401,361	—	—	—	$198,070	$13,800	$613,231

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Paul Peter Tak	M.D., Ph.D, FMedSci, Chief Executive Officer	$670,000	—	$176,506	$189,558	$134,000	$314,695	$1,484,759
Francesca Barone	M.D., Chief Scientific Officer	$413,005	—	$110,534	$89,577	$80,560	$13,200	$706,876
Jason A. Amello	Former Chief Financial Officer	$466,045	—	$123,203	$89,577	—	$13,200	$692,025

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Paul Peter Tak	M.D., Ph.D, FMedSci, Chief Executive Officer	$670,000	—	$334,999	$351,043	$259,625	$229,304	$1,844,971
Seshu Tyagarajan	Ph.D., RACChief Technical and DevelopmentOfficer	$235,385	$20,000	$126,000	$454,752	$73,238	$6,646	$916,020
Francesca Barone	M.D., Chief Scientific Officer	$362,192	—	$155,400	$233,988	$144,522	$12,200	$908,302

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Paul Peter Tak	M.D., Ph.D, FMedSci,Chief Executive Officer	$545,116	$85,000	—	—	$167,500	$159,184	$956,800
Estuardo Aguilar-Cordova	M.D., inf., Ph.D., Founder and Former Chief Executive Officer and Chief Scientific Officer	$520,192	—	—	—	—	$6,194	$526,386
John Canepa	Chief Financial Officer	$370,000	—	—	—	$74,000	$5,123	$449,123
Francesca Barone	M.D., Ph.D.Chief Scientific Officer	$259,728	—	—	—	$101,500	$3,569	$364,797
Seshu Tyagarajan	Ph.D., RACChief Technical and DevelopmentOfficer	—	—	—	—	—	—	—

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Paul Peter Tak	M.D., Ph.D., FMedSci, President and Chief Executive Officer	$134,615	$85,000	—	$2,316,446	$90,450	—	$2,626,511
John Canepa	Chief Financial Officer	$14,231	$75,000	—	$1,230,085	—	—	$1,319,316
Estuardo Aguilar-Cordova	M.D., inf., Ph.D., Founder and Former Chief Executive Officer and Chief Scientific Officer	$444,903	$104,000	—	—	$191,250	—	$740,153

Key facts CIK 1841387 CUSIP 137404109 13F (30d) 116 filings 116 filers Visit website Investor relations